Edarbi (Azilsartan) for Heart disease | MyHeartDiseaseTeam

Connect with others who understand.

sign up Log in
Resources
About MyHeartDiseaseTeam
Powered By

Overview
Edarbi is a prescription drug approved by the Food and Drug Administration (FDA) to treat hypertension. Edarbi is also known by its drug name, Azilsartan.

Edarbi is an angiotensin II receptor blocker (ARB). ARBs are believed to work by relaxing the blood vessels.

How do I take it?
Edarbi is generally taken once daily.

Edarbi comes in tablet form.

Side effects
The FDA-approved label for Edarbi lists common side effects including diarrhea.

Rare but serious side effects listed for Edarbi include fetal toxicity.

For more details about this treatment, visit:
Edarbi – Arbor
https://www.edarbi.com/

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in